The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis

Annals of the Rheumatic Diseases

Volumn 67, Issue 11, 2008, Pages 1578-1580

  Albers, H M ^a   Kurreeman, F A S ^a   Houwing Duistermaat, J J ^a   Brinkman, D M C ^a   Kamphuis, S S M ^b   Girschick, H J ^c   Wouters, C ^d   Van Rossum, M A J ^e   Verduijn, W ^a   Toes, R E M ^a   Huizinga, T W J ^a   Schilham, M W ^a   Ten Cate, R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e EMMA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1;

ALLELE; ARTICLE; CHROMOSOME 9Q; CONTROLLED STUDY; GENE FREQUENCY; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; POLYARTHRITIS; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CASE-CONTROL STUDIES; CHILD; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TNF RECEPTOR-ASSOCIATED FACTOR 1;

EID: 51849101809     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2008.089060     Document Type: Article

References (10)

1. Manners PJ, Bower C. Worldwide prevalence of juvenile arthritis why does it vary so much? J Rheumatol 2002;29:1520-30.
2. Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
3. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet 2007;369:767-78.
4. Saurenmann RK, Rose JB, Tyrrell P, Feldman BM, Laxer RM, Schneider R, et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum 2007;56:1974- 84.
5. Phelan JD, Thompson SD. Genomic progress in pediatric arthritis: recent work and future goals. Curr Opin Rheumatol 2006;18:482-9.
6. Kurreeman FAS, Padyukov L, Marques RB, Schrodi SJ, Seddighzadeh M, Stoeken-Rijsbergen G, et al. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 2007;4:e278.
7. Plenge RM, Seielstad M, Padyukov L, Lee AT, Remmers EF, Ding B, et al. TRAF1-C5 as a risk locus for rheumatoid arthritis - a genomewide study. N Engl J Med 2007;357:1199-209.
8. Jarvis JN. Pathogenesis and mechanisms of inflammation in the childhood rheumatic diseases. Curr Opin Rheumatol 1998;10:459-67.
9. Tsitsikov EN, Laouini D, Dunn IF, Sannikova TY, Davidson L, Alt FW, et al. TRAF1 is a negative regulator of TNF signaling: enhanced TNF signaling in TRAF1-deficient mice. Immunity 2001;15:647-57.
10. Lovell DJ, Reiff A, Jones OY, Schneider R, Norton J, Stein LD, et al. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 2006;54:1987-94.